BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36289663)

  • 21. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.
    Berglin E; Johansson T; Sundin U; Jidell E; Wadell G; Hallmans G; Rantapää-Dahlqvist S
    Ann Rheum Dis; 2006 Apr; 65(4):453-8. PubMed ID: 16176994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-cyclic citrullinated peptide antibody titers decrease in rheumatoid arthritis patients treated with tocilizumab: A pilot study.
    Noguchi A; Yasuda S; Hisada R; Kato M; Oku K; Bohgaki T; Suzuki M; Matsumoto Y; Atsumi T
    Mod Rheumatol; 2020 Mar; 30(2):276-281. PubMed ID: 30789096
    [No Abstract]   [Full Text] [Related]  

  • 23. Anti-citrullinated protein antibodies in the diagnosis of rheumatoid arthritis (RA): diagnostic performance of automated anti-CCP-2 and anti-CCP-3 antibodies assays.
    Vos I; Van Mol C; Trouw LA; Mahler M; Bakker JA; Van Offel J; De Clerck L; Huizinga TW
    Clin Rheumatol; 2017 Jul; 36(7):1487-1492. PubMed ID: 28578492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Cyclic Citrullinated Peptide Antibody Level on Progression to Rheumatoid Arthritis in Clinically Tested Cyclic Citrullinated Peptide Antibody-Positive Patients Without Rheumatoid Arthritis.
    Ford JA; Liu X; Marshall AA; Zaccardelli A; Prado MG; Wiyarand C; Lu B; Karlson EW; Schur PH; Deane KD; Sparks JA
    Arthritis Care Res (Hoboken); 2019 Dec; 71(12):1583-1592. PubMed ID: 30570827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is Anti Cyclic citrullinated peptide a useful laboratory test for the diagnosis of rheumatoid arthritis?
    Girelli F; Foschi FG; Bedeschi E; Calderoni V; Stefanini GF; Martinelli MG
    Eur Ann Allergy Clin Immunol; 2004 Apr; 36(4):127-30. PubMed ID: 15180353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative evaluation of treatment patterns and healthcare utilization of newly-diagnosed rheumatoid arthritis patients by anti-cyclic citrullinated peptide antibody status.
    Lamerato L; Price K; Szymialis R; Eaddy M; Ogbonnaya A; Shih HC; Ahmad H
    J Med Econ; 2018 Mar; 21(3):231-240. PubMed ID: 29027497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies to a new viral citrullinated peptide, VCP2: fine specificity and correlation with anti-cyclic citrullinated peptide (CCP) and anti-VCP1 antibodies.
    Pratesi F; Tommasi C; Anzilotti C; Puxeddu I; Sardano E; Di Colo G; Migliorini P
    Clin Exp Immunol; 2011 Jun; 164(3):337-45. PubMed ID: 21413944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.
    Snir O; Widhe M; Hermansson M; von Spee C; Lindberg J; Hensen S; Lundberg K; Engström A; Venables PJ; Toes RE; Holmdahl R; Klareskog L; Malmström V
    Arthritis Rheum; 2010 Jan; 62(1):44-52. PubMed ID: 20039432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
    Us D; Gülmez D; Hasçelik G
    Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis.
    Shovman O; Gilburd B; Zandman-Goddard G; Sherer Y; Orbach H; Gerli R; Shoenfeld Y
    Clin Dev Immunol; 2005 Sep; 12(3):197-202. PubMed ID: 16295525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-cyclic citrullinated peptide antibody in systemic sclerosis.
    Morita Y; Muro Y; Sugiura K; Tomita Y
    Clin Exp Rheumatol; 2008; 26(4):542-7. PubMed ID: 18799082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Basal anti-cyclic citrullinated peptide (anti-CCP) antibody levels and a decrease in anti-CCP titres are associated with clinical response to adalimumab in rheumatoid arthritis.
    Cuchacovich M; Catalan D; Wainstein E; Gatica H; Soto L; Aravena O; Pesce B; Sabugo F; Aguillón JC
    Clin Exp Rheumatol; 2008; 26(6):1067-73. PubMed ID: 19210871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of serum collagen triple helix repeat containing-1(CTHRC1) and 14-3-3η protein compared to anti-CCP antibodies and anti-MCV antibodies in the diagnosis of rheumatoid arthritis.
    Hu T; Liu Y; Tan L; Huang J; Yu J; Wu Y; Pei Z; Zhang X; Li J; Song L; Dai W; Xiang Y
    Br J Biomed Sci; 2021 Apr; 78(2):67-71. PubMed ID: 32813981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salivary IgA antibodies to cyclic citrullinated peptides (CCP) in rheumatoid arthritis.
    Svärd A; Kastbom A; Sommarin Y; Skogh T
    Immunobiology; 2013 Feb; 218(2):232-7. PubMed ID: 22652412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis and Behçet's disease.
    Koca SS; Akbulut H; Dag S; Artas H; Isik A
    Tohoku J Exp Med; 2007 Dec; 213(4):297-304. PubMed ID: 18075233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic value of anti-modified citrullinated vimentin in rheumatoid arthritis.
    Maraina CH; Nurdayana AK; Rusni D; Azwany Y
    Int J Rheum Dis; 2010 Oct; 13(4):335-9. PubMed ID: 21199468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diagnostic utilities of anti-agalactosyl IgG antibodies, anti-cyclic citrullinated peptide antibodies, and rheumatoid factors in rheumatoid arthritis.
    Ryu HJ; Takeuchi F; Kuwata S; Kim YJ; Lee EY; Lee EB; Song YW
    Rheumatol Int; 2011 Mar; 31(3):315-9. PubMed ID: 20012964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the analytical and clinical performances of four anti-cyclic citrullinated peptide antibody assays for diagnosing rheumatoid arthritis.
    Cho J; Pyo JY; Fadriquela A; Uh Y; Lee JH
    Clin Rheumatol; 2021 Feb; 40(2):565-573. PubMed ID: 32964298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Usefulness of anti-cyclic citrullinated peptide antibodies (anti-CCP) for the diagnosis of rheumatoid arthritis].
    Araki C; Hayashi N; Moriyama M; Morinobu S; Mukai M; Koshiba M; Kawano S; Kumagai S
    Rinsho Byori; 2004 Dec; 52(12):966-72. PubMed ID: 15675342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide 2 antibody and anti-cyclic citrullinated peptide 3 antibody in rheumatoid arthritis.
    Zhang WC; Wu H; Chen WX
    Clin Chem Lab Med; 2014 Jun; 52(6):779-90. PubMed ID: 24445240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.